Mechanistically, PI3K/Akt/mTOR signaling pathway has been shown to regulate cell growth, differentiation, proliferation, metastasis and chemoradiotherapy sensitivity in ESCC [42]. Here, AKT1 is linked to esophageal squamous cell carcinoma.